Assignee
ANSUN BIOPHARMA INC
US·12 granted patents·43 pending applications·40 citations·filing 2013–2025
Top patents by PatentIndex Score
55 records- 0192US8722869B2Class of therapeutic protein based moleculesANSUN BIOPHARMA INC·Filed 2013·Granted May 13, 2014·12 cites·27 claims
- 0290US10328128B2Treatment of infection by human enterovirus D68ANSUN BIOPHARMA INC·Filed 2015·Granted Jun 25, 2019·6 cites·6 claims
- 0388US10525109B2Class of therapeutic protein based moleculesANSUN BIOPHARMA INC·Filed 2017·Granted Jan 7, 2020·4 cites·4 claims
- 0486US10351828B2Method of protein purification from E. coliANSUN BIOPHARMA INC·Filed 2014·Granted Jul 16, 2019·6 cites·30 claims
- 0586US9764007B2Class of therapeutic protein based moleculesANSUN BIOPHARMA INC·Filed 2015·Granted Sep 19, 2017·4 cites·16 claims
- 0681US9700602B2Microparticle formulations for delivery to the lower and central respiratory tract and methods of manufactureANSUN BIOPHARMA INC·Filed 2016·Granted Jul 11, 2017·2 cites·23 claims
- 0781US9212353B2Class of therapeutic protein based moleculesANSUN BIOPHARMA INC·Filed 2014·Granted Dec 15, 2015·3 cites·15 claims
- 0875US2021353719A1Microparticle Formulations for Delivery to the Lower and Central Respiratory Tract and Methods of ManufactureANSUN BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 0974US2019060239A1Technology for the Preparation of MicroparticlesANSUN BIOPHARMA INC·Filed 2018·Application pending·0 cites
- 1074US2020164048A1Microparticle Formulations for Delivery to the Lower and Central Respiratory Tract and Methods of ManufactureANSUN BIOPHARMA INC·Filed 2019·Application pending·0 cites
- 1174US2015050713A1Technology for the Preparation of MicroparticlesANSUN BIOPHARMA INC·Filed 2014·Application pending·0 cites
- 1271US10300116B2Treatment for BK polyomavirus infectionANSUN BIOPHARMA INC·Filed 2014·Granted May 28, 2019·3 cites·25 claims
- 1371US2021046165A1Methods, Compounds and Compositions for Treatment of Influenza and Parainfluenza PatientsANSUN BIOPHARMA INC·Filed 2020·Application pending·0 cites
- 1470US2018028449A1Technology for the Preparation of MicroparticlesANSUN BIOPHARMA INC·Filed 2017·Application pending·0 cites
- 1570US2014099696A1Technology for the Preparation of MicroparticlesANSUN BIOPHARMA INC·Filed 2013·Application pending·0 cites
- 1669US2017079920A1Technology for the Preparation of MicroparticlesANSUN BIOPHARMA INC·Filed 2016·Application pending·0 cites
- 1769US2025387457A1Methods, Compounds and Compositions for Treatment of Influenza and Parainfluenza PatientsANSUN BIOPHARMA INC·Filed 2025·Application pending·0 cites
- 1868US2020197310A1Technology for Preparation of Macromolecular MicrospheresANSUN BIOPHARMA INC·Filed 2020·Application pending·0 cites
- 1967US10583086B2Technology for preparation of macromolecular microspheresANSUN BIOPHARMA INC·Filed 2017·Granted Mar 10, 2020·0 cites·10 claims
- 2067US2016235675A1Technology for the Preparation of MicroparticlesANSUN BIOPHARMA INC·Filed 2016·Application pending·0 cites
- 2166US2020016243A1Treatment of infection by human enterovirus d68ANSUN BIOPHARMA INC·Filed 2019·Application pending·0 cites
- 2265US2020297822A1Methods, Compounds, and Compositions For Treatment and Prophylaxis in the Respiratory TractANSUN BIOPHARMA INC·Filed 2020·Application pending·0 cites
- 2365US2015359746A1Technology for the Preparation of MicroparticlesANSUN BIOPHARMA INC·Filed 2015·Application pending·0 cites
- 2465US2021330758A1Treatment for bk polyomavirus infectionANSUN BIOPHARMA INC·Filed 2020·Application pending·0 cites
- 2564US11191817B2Treatment of infection by human enterovirus D68ANSUN BIOPHARMA INC·Filed 2020·Granted Dec 7, 2021·0 cites·8 claims
- 2664US2014134150A1Technology for preparation of macromolecular microspheresANSUN BIOPHARMA INC·Filed 2014·Application pending·0 cites
- 2763US11697803B2Method of protein purification from E.coliANSUN BIOPHARMA INC·Filed 2019·Granted Jul 11, 2023·0 cites·18 claims
- 2862US2020016244A1Treatment for bk polyomavirus infectionANSUN BIOPHARMA INC·Filed 2019·Application pending·0 cites
- 2960US2025257345A1Das181 variant compositionsANSUN BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 3060US2014099380A1Microparticle Formulations for Delivery to the Lower and Central Respiratory Tract and Methods of ManufactureANSUN BIOPHARMA INC·Filed 2013·Application pending·0 cites
- 3159US2018193432A1Anti-viral therapeutic for infection of the eyeANSUN BIOPHARMA INC·Filed 2017·Application pending·0 cites
- 3259US2015017150A1Methods, Compounds, and Compositions For Treatment and Prophylaxis in the Respiratory TractANSUN BIOPHARMA INC·Filed 2014·Application pending·0 cites
- 3359US2017312346A1Microparticle Formulations for Delivery to the Lower and Central Respiratory Tract and Methods of ManufactureANSUN BIOPHARMA INC·Filed 2017·Application pending·0 cites
- 3458US2020390868A1Anti-viral therapeutic for infection of the eyeANSUN BIOPHARMA INC·Filed 2020·Application pending·0 cites
- 3557US2015290134A1Technology for preparation of macromolecular microspheresANSUN BIOPHARMA INC·Filed 2015·Application pending·0 cites
- 3657US2023149487A1Delivery of sialidase to cancer cells, immune cells and the tumor microenvironmentANSUN BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 3757US2018140683A1Methods, Compounds, and Compositions For Treatment and Prophylaxis in the Respiratory TractANSUN BIOPHARMA INC·Filed 2018·Application pending·0 cites
- 3856US2020164049A1Treatment of human metapneumovirusANSUN BIOPHARMA INC·Filed 2020·Application pending·0 cites
- 3955US2020222511A1Treatment of merkel cell polyomavirus infectionANSUN BIOPHARMA INC·Filed 2019·Application pending·0 cites
- 4054US11241486B2Treatment of Middle East respiratory syndrome coronavirusANSUN BIOPHARMA INC·Filed 2020·Granted Feb 8, 2022·0 cites·10 claims
- 4154US2022233657A1Treatment of middle east respiratory syndrome coronavirusANSUN BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 4254US2013280332A1Methods, Compounds and Compositions for Treatment of Influenza and Parainfluenza PatientsANSUN BIOPHARMA INC·Filed 2013·Application pending·0 cites
- 4354US2023330140A1Immune cell delivery of sialidase cancer cells, immune cells and the tumor microenvironmentANSUN BIOPHARMA INC·Filed 2020·Application pending·0 cites
- 4453US2016228518A1Methods, Compounds, and Compositions For Treatment and Prophylaxis in the Respiratory TractANSUN BIOPHARMA INC·Filed 2016·Application pending·0 cites
- 4553US2017151315A1Methods, Compounds and Compositions for Treatment of Influenza and Parainfluenza PatientsANSUN BIOPHARMA INC·Filed 2017·Application pending·0 cites
- 4652US2016120961A1Treatment of merkel cell polyomavirus infectionANSUN BIOPHARMA INC·Filed 2014·Application pending·0 cites
- 4752US2014342006A1Methods for Preparing Injectable Protein Microparticle SuspensionsANSUN BIOPHARMA INC·Filed 2014·Application pending·0 cites
- 4851US2022370527A1Delivery of sialidase to cancer cells, immune cells and the tumor microenvironmentANSUN BIOPHARMA INC·Filed 2019·Application pending·0 cites
- 4950US2019262432A1Treatment of middle east respiratory syndrome coronavirusANSUN BIOPHARMA INC·Filed 2019·Application pending·0 cites
- 5047US2015132274A1Methods, Compounds and Compositions for Treatment of Influenza and Parainfluenza PatientsANSUN BIOPHARMA INC·Filed 2015·Application pending·0 cites
Showing the top 50 of 55 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when ANSUN BIOPHARMA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →